Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine in Anorexia Nervosa
NCT00592930Phase 4Completed
- Sponsor
- Northwell Health
- Start
- Jun 2000
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anorexia nervosa (AN) comparing olanzapine with matching placebo (2 arms). Primary endpoint: Weight gain at 10 weeks. Started Jun 2000; status: completed.
02
Drugs
olanzapine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT00592930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00592930.